Overview

The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation

Status:
NOT_YET_RECRUITING

Trial end date:
2027-06-22

Target enrollment:

Participant gender:

Summary

The aim for this clinical trial is to evaluate if colchicine in addition to standard of care improves insulin sensitivity in individuals with type 1 diabetes, systemic low-grade inflammaiton and reduced insulin sensitivity. The insulin sensitivity will be evaluated by a hyperinsulinemic, euglycemic clamp.

Phase:

PHASE2

Details

Lead Sponsor:

Asger Lund, MD

Collaborator:

University of Copenhagen

Treatments:

Colchicine